(S,R,S)-AHPC-C10-NH2 dihydrochloride is a high-purity E3 Ligase Ligand-Linker Conjugate engineered for advanced PROTAC (Proteolysis Targeting Chimera) research and drug discovery. This molecule features the (S,R,S)-AHPC moiety, a well-established ligand for the von Hippel-Lindau (VHL) E3 ubiquitin ligase, attached via a 10-carbon flexible linker to an amino-terminal group, providing versatile conjugation options for PROTAC synthesis. By recruiting VHL E3 ligase to target proteins, this conjugate enables their selective ubiquitination and proteasomal degradation. As a critical component in designing bifunctional molecules, (S,R,S)-AHPC-C10-NH2 dihydrochloride facilitates the exploration of novel therapeutics against previously 'undruggable' targets. Suitable for medicinal chemistry, chemical biology, and targeted protein degradation studies, this compound accelerates the development of next-generation small-molecule degraders in oncology, neurodegeneration, and other therapeutic areas.
Structure of 2341796-75-4
* For research and manufacturing use only. Not for human or clinical use.
| Size | Price | Stock | Quantity |
|---|---|---|---|
| 50 mg | $399 | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Popular Publications Citing BOC Sciences Products
Background Introduction
(S,R,S)-AHPC-C10-NH2 dihydrochloride is a specialized E3 ligase ligand-linker conjugate widely used in the development of PROTACs (Proteolysis Targeting Chimeras). As a derivative of the AHPC ligand, it selectively binds to the von Hippel-Lindau (VHL) E3 ubiquitin ligase. The C10 amino-linked structure provides a versatile functional handle, enabling seamless conjugation with diverse target-binding moieties for efficient protein degradation studies.
Mechanism
The mechanism of action of (S,R,S)-AHPC-C10-NH2 dihydrochloride leverages its high affinity and specificity for the VHL E3 ubiquitin ligase. When incorporated into a PROTAC molecule, the AHPC moiety binds to VHL, while the amino group at the C10 linker site allows attachment to a ligand for a protein of interest. This heterobifunctional molecule brings the target protein into close proximity with the VHL complex, which, in turn, facilitates ubiquitination and subsequent proteasomal degradation of the target. This targeted approach ensures selective depletion of disease-relevant proteins, overcoming many drawbacks of traditional inhibition.
Applications
(S,R,S)-AHPC-C10-NH2 dihydrochloride is a critical intermediate for the synthesis of VHL-based PROTACs and molecular glues. Its utility spans research and drug discovery applications, including targeted protein degradation, elucidation of protein function, validation of novel therapeutic targets, and development of next-generation therapeutics for cancer, neurodegenerative disorders, and other diseases. The product's linker with a terminal amine allows for flexible conjugation strategies, supported by robust structure-activity relationships (SAR) studies in medicinal chemistry and chemical biology applications.
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
Please contact us with any specific requirements and we will get back to you as soon as possible.